Tari Ao Whānui

3 o Hakihea, 2024, kua whakaaetia te rongoā auaha Zepzelca (lurbinectedin mō te werohanga) kia hokohokohia e te Whakahaere Hua Hauora ā-Motu o Haina (NMPA) mā te kaupapa arotake matua. Kua tohua te rongoā mō te maimoatanga o ngā tūroro pakeke e pangia ana e te mate pūkahukahu pūtau iti kua horapa...Pānuihia atu»

I te 31 o Hakihea, kua whakaaetia e te Whakahaere Hua Hauora ā-Motu o Haina (NMPA) te VYLOYTM (zolbetuximab), me te rongoā chemotherapy kei roto ko te fluoropyrimidine me te platinum, hei rongoā tuatahi mō ngā tūroro e tipu ana te kiriuhi tangata kua horapa ki te rohe, kāore e taea te tango, kua horapa rānei...Pānuihia atu»

31 Hakihea 2024，Kua whiwhi a Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kamupene") i te whakaaetanga hokohoko i Haina mai i te National Medical Products Administration (NMPA) mō te paturopi monoclonal tangata auaha ("mAb") tagitanlim e ārahi ana i te ligand1 (PD-L1) mate pūtau kua whakaritea...Pānuihia atu»

Ko te C-CAR031 he rongoā ā-aunoa, he mea hanga ki te GPC3, he mea hanga ki te ārai mate kiriuhi chimeric (CAR-T), e rangahauhia ana mō te rongoā i te HCC. E hangai ana ki tētahi CAR-T hou e hangai ana ki te GPC3, i hangaia e AstraZeneca mā te whakamahi i tā rātou matū matua kino-beta-receptor II matua kino...Pānuihia atu»

Hakihea 20, 2024, kua whakaaetia e te Whakahaere Hua Hauora ā-Motu o Haina (NMPA) tētahi Tono Rongoā Hou (NDA) o te DOVBLERON ® (taletrectinib adipate capsule), he aukati ROS1 tyrosine kinase (TKI) o te whakatupuranga hou, hei rongoā mō ngā tūroro pakeke e pāngia ana e te ROS kua horapa ki te rohe, kua horapa rānei...Pānuihia atu»

Ko te C-CAR031 he rongoā ā-aunoa, he mea hanga ki te GPC3, he mea hanga ki te ārai mate kiriuhi chimeric (CAR-T), e rangahauhia ana mō te rongoā i te HCC. I whakaaturia ā-waha te ahunga whakamua o te rangahau o te C-CAR031 i roto i te mate pukupuku hepatocellular (HCC) i te hui ā-tau a te American Society of Clinical Oncology (ASCO) i te...Pānuihia atu»

He rongoā pūtau-aunoa te GT101 i hangaia mai i te TIL kua whakawhānuihia, kua whakahoutia mai i te puku o te tūroro. Ka tukuna te rongoā mā te hauhake i te kiko puku mai i ngā tūroro me te tango i te TIL. Kātahi ka whakanuia te TIL kua tangohia mā te whakamahi i te tūāpapa hanga motuhake a Grit Bio, a StemTe...Pānuihia atu»

Ko ngā pūtau TAEST16001 he pūtau-T autologous i hangaia ira e whakaatu ana i te kaiwhakawhiwhi pūtau-T NY-ESO-1-motuhake (TCR) e aro ana ki te NY-ESO-1 (e whakaatuhia ana i roto i te whānuitanga o ngā pukupuku) te sarcoma kiko ngohengohe pai (STS) i roto i te horopaki o te HLA-A*02:01. He rangahau wāhanga I mō ngā tūroro me te S matatau...Pānuihia atu»

Hakihea 04, 2024, kua whakaaetia ā-ture te Tono Rongoā Hou (NDA) mō te whakakotahitanga o te TYVYT® (werohanga sintilimab) me te ELUNATE® (fruquintinib) i Haina mō te maimoatanga o ngā tūroro he mate pukupuku endometrial matatau me ngā pukupuku Mismatch Repair proficient (pMMR) kua ...Pānuihia atu»

Ko te GC203 he rongoā TIL hou kāore i te huaketo kua whakarerekētia e te ira, i whakawhanakehia mā te whakamahi i te tūāpapa whakawhānui pūtau DeepTIL® a Juncell Therapeutics me te tūāpapa whakarerekētanga ira NovaGMP®. Mā te DeepTIL® ka taea e ngā TIL te kaha kia kore ai e hiahiatia he huinga IL-2 i muri i te werohanga, he...Pānuihia atu»

Ko te Glioblastoma Multiforme (GBM) tētahi o ngā mate pukupuku tino whakamate, ā, tata ki te katoa o ngā tūroro ka hoki anō ki te mate i runga i te paerewa tiaki o nāianei mō te GBM hou kua kitea. Ko te GBM e hoki anō ana (rGBM) e whakaatu ana i te oranga toharite o raro iho i te 8 marama me ngā kōwhiringa rongoā iti. Ko te TX103 he CAR-T ce...Pānuihia atu»

He hua pūtau CAR-T whānui te RD13-02 e aro ana ki te CD7 i ahu mai i ngā kaituku hauora, ā, i hangaia mō te rongoā i te mate toto toto nui/lymphoma lymphoblastic acute pūtau-T (T-ALL/LBL) kua hoki mai, kua uaua rānei te rongoā. Kua whakarerekētia te ira hei karo i te whakamate i te whanaunga, te mate graft-versus-host (GvHD), me te mate host-versus-...Pānuihia atu»